POD24 in MZL: a means to an end or an end point in itself?

od Maurer, Matthew J.
Wydane w Blood (2019)

Survival prediction based on inherited gene variation analysis

od Cicek, Mine S., Maurer, Matthew J., Goode, Ellen L.
Wydane 2013

Degradation of a Cytosolic Protein Requires Endoplasmic Reticulum-associated Degradation Machinery

od Metzger, Meredith Boyle, Maurer, Matthew J., Dancy, Beverley M., Michaelis, Susan
Wydane 2008

Effect of Coenzyme Q10 on Doxorubicin Cytotoxicity in Breast Cancer Cell Cultures

od Greenlee, Heather, Shaw, Jacquelyn, Lau, Ying-Ka Ingar, Naini, Ali, Maurer, Matthew
Wydane 2012

Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53

od Resnick-Silverman, Lois, St. Clair, Selvon, Maurer, Matthew, Zhao, Kathy, Manfredi, James J.
Wydane 1998

PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling

od Wang, Xiaoqi, Li, Guangyuan, Koul, Sanjay, Ohki, Rieko, Maurer, Matthew, Borczuk, Alain, Halmos, Balazs
Wydane w Oncotarget (2015)

Degradation Signals for Ubiquitin-Proteasome Dependent Cytosolic Protein Quality Control (CytoQC) in Yeast

od Maurer, Matthew J., Spear, Eric D., Yu, Allen T., Lee, Evan J., Shahzad, Saba, Michaelis, Susan
Wydane w G3 (Bethesda) (2016)

JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis

od Le, Kang, Wellik, Linda E., Maurer, Matthew J., McPhail, Ellen D., Witzig, Thomas E., Gupta, Mamta
Wydane w Blood Cancer J (2021)

A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells

od Reid, Robert J. D., Du, Xing, Sunjevaric, Ivana, Rayannavar, Vinayak, Dittmar, John, Bryant, Eric, Maurer, Matthew, Rothstein, Rodney
Wydane w Genetics (2016)

Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies

od Ravi, Praful, Kumar, Shaji K., Cerhan, James R., Maurer, Matthew J., Dingli, David, Ansell, Stephen M., Rajkumar, S. Vincent
Wydane w Blood Cancer J (2018)

Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review

od Bataillard, Edward J., Cheah, Chan Yoon, Maurer, Matthew J., Khurana, Arushi, Eyre, Toby A., El-Galaly, Tarec Christoffer
Wydane w Blood Adv (2021)

Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation

od Gupta, Mamta, Han, Jing Jing, Stenson, Mary, Maurer, Matthew, Wellik, Linda, Hu, Guangzhen, Ziesmer, Steve, Dogan, Ahmet, Witzig, Thomas E.
Wydane 2012

Elevated serum monoclonal and polyclonal free light chains and Interferon inducible protein-10 (IP-10) predicts inferior prognosis in untreated diffuse large B-cell lymphoma

od Witzig, Thomas E., Maurer, Matthew J., Stenson, Mary J., Allmer, Cristine, Macon, William, Link, Brian, Katzmann, Jerry A., Gupta, Mamta
Wydane 2014

The Frailty Phenotype and Palliative Care Needs In Older Survivors of Critical Illness

od Pollack, Lauren R., Goldstein, Nathan E., Gonzalez, Wendy C., Blinderman, Craig D., Maurer, Matthew S., Lederer, David J., Baldwin, Matthew R.
Wydane w J Am Geriatr Soc (2017)

Phase I study of erlotinib and metformin in metastatic triple negative breast cancer

od Fenn, Kathleen, Maurer, Matthew, Lee, Shing M., Crew, Katherine D., Trivedi, Meghna S., Accordino, Melissa K., Hershman, Dawn L., Kalinsky, Kevin
Wydane w Clin Breast Cancer (2019)

Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A

od Torres, Diogo, Hou, Xiaonan, Bale, Laurie, Heinzen, Ethan P., Maurer, Matthew J., Zanfagnin, Valentina, Oberg, Ann L., Conover, Cheryl, Weroha, S. John
Wydane w PLoS One (2019)

Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214

od Escudier, Bernard, Motzer, Robert J., Tannir, Nizar M., Porta, Camillo, Tomita, Yoshihiko, Maurer, Matthew, McHenry, M. Brent, Rini, Brian I.
Wydane w Eur Urol (2019)

Use of a Urine Anastrozole Assay to Determine Treatment Discontinuation Among Women With Hormone-Sensitive Breast Cancer: A Pilot Study

od Clarke Hillyer, Grace, Neugut, Alfred I., Crew, Katherine D., Kalinsky, Kevin, Maurer, Matthew A., Rotsides, Demetra Z., Danaceau, Jonathan, Hershman, Dawn L.
Wydane 2012

Plasma immune analytes in patients with epithelial ovarian cancer

od Block, Matthew S., Maurer, Matthew J., Goergen, Krista, Kalli, Kimberly R., Erskine, Courtney L., Behrens, Marshall D., Oberg, Ann L., Knutson, Keith L.
Wydane w Cytokine (2015)

Compliance with Cancer Screening and Influenza Vaccination guidelines in Non-Hodgkin Lymphoma Survivors

od Pophali, Priyanka A., Larson, Melissa C., Allmer, Cristine, Farooq, Umar, Link, Brian K., Maurer, Matthew J., Cerhan, James R., Thompson, Carrie A.
Wydane w J Cancer Surviv (2020)